All data are based on the daily closing price as of October 30, 2025
r

Rohto Pharmaceutical

4527.TSE
15.65 USD
0.19
+1.23%

Overview

Last close
15.65 usd
Market cap
3.54B usd
52 week high
25.80 usd
52 week low
13.77 usd
Target price
18.12 usd

Valuation

P/E
17.4946
Forward P/E
N/A
Price/Sales
1.662
Price/Book Value
2.0992
Enterprise Value
3.47B usd
EV/Revenue
1.727
EV/EBITDA
9.4462

Key financials

Revenue TTM
2.10B usd
Gross Profit TTM
1.18B usd
EBITDA TTM
342.93M usd
Earnings per Share
0.88 usd
Dividend
0.23 usd
Total assets
2.97B usd
Net debt
-187.08M usd

About

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatological, gastrointestinal, and diagnostic drugs, as well as Chinese herbal medicines, and supplements. In addition, the company operates beauty counters that provide beauty and health services; and manufactures and sells diagnostic reagents, as well as provides investment management services; and contract development and manufacturing services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. The company was founded in 1899 and is headquartered in Osaka, Japan.
  • Symbol
    4527.TSE
  • Exchange
    TSE
  • Isin
    JP3982400008
  • Country
    Japan
  • Sector
    Consumer Defensive
  • Industry
    Household & Personal Products
  • CEO
    Mr. Yamada Kunio
  • Headquarter
    Osaka
  • Web site
    https://www.rohto.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top